Northern Trust Corp Assembly Biosciences, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.65 - $1.25 $14,992 - $28,832	23,066 Added 21.33%	131,182 $107,000
Q2 2023 Aug 11, 2023	BUY	$0.81 - $1.15 $7,869 - $11,173	9,716 Added 9.87%	108,116 $124,000
Q1 2023 May 15, 2023	BUY	$0.8 - $1.74 $5,542 - $12,054	6,928 Added 7.57%	98,400 $82,000
Q4 2022 Feb 13, 2023	SELL	$1.09 - $1.52 $361 - $504	-332 Reduced 0.36%	91,472 $118,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.34 $4,545 - $6,257	2,674 Added 3.0%	91,804 $151,000

Q2 2022 Aug 12, 2022	SELL	$1.35 - $2.29 $4,822 - $8,179	-3,572 Reduced 3.85%	89,130 $187,000
Q1 2022 May 13, 2022	SELL	$1.46 - $2.45 $14,408 - $24,179	-9,869 Reduced 9.62%	92,702 $191,000
Q4 2021 Feb 08, 2022	SELL	$2.13 - $3.46 $8,743 - $14,203	-4,105 Reduced 3.85%	102,571 $239,000
Q3 2021 Nov 15, 2021	BUY	$3.14 - $3.9 $14,170 - $17,600	4,513 Added 4.42%	106,676 $371,000
Q2 2021 Aug 13, 2021	SELL	$3.8 - $4.56 $1.02 Million - $1.23 Million	-268,964 Reduced 72.47%	102,163 $396,000
Q1 2021 May 12, 2021	SELL	$4.33 - $6.63 $97,082 - $148,651	-22,421 Reduced 5.7%	371,127 $1.71 Million
Q4 2020 Feb 11, 2021	SELL	$4.87 - $17.29 $79,195 - $281,169	-16,262 Reduced 3.97%	393,548 $2.38 Million
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $190,369 - $341,352	-12,624 Reduced 2.99%	409,810 $6.74 Million
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $736,222 - $1.21 Million	50,530 Added 13.59%	422,434 $9.85 Million
Q1 2020 May 14, 2020	BUY	$10.27 - $21.23 $776,052 - $1.6 Million	75,565 Added 25.5%	371,904 $5.52 Million
Q4 2019 Feb 14, 2020	SELL	$8.36 - $23.81 $17,221 - $49,048	-2,060 Reduced 0.69%	296,339 $6.06 Million
Q3 2019 Nov 13, 2019	BUY	$9.83 - $14.82 $166,412 - $250,887	16,929 Added 6.01%	298,399 $2.93 Million
Q2 2019 Aug 13, 2019	SELL	$12.9 - $20.8 $122,240 - $197,100	-9,476 Reduced 3.26%	281,470 $3.8 Million
Q1 2019 May 13, 2019	BUY	$17.7 - $24.93 $97,190 - $136,890	5,491 Added 1.92%	290,946 $5.73 Million
Q4 2018 Feb 12, 2019	SELL	$19.05 - $36.45 $129,197 - $247,203	-6,782 Reduced 2.32%	285,455 $6.46 Million
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $1.76 Million - $2.26 Million	51,074 Added 21.18%	292,237 $10.9 Million
Q2 2018 Sep 18, 2018	SELL	$39.21 - $50.29 $45,287 - $58,084	-1,155 Reduced 0.48%	241,163 $9.46 Million
Q2 2018 Aug 14, 2018	BUY	$39.21 - $50.29 $757,458 - $971,502	19,318 Added 8.66%	242,318 $9.5 Million
Q1 2018 May 09, 2018	BUY	$41.7 - $64.16 $121,096 - $186,320	2,904 Added 1.32%	223,000 $11 Million
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $832,821 - $1.45 Million	29,140 Added 15.26%	220,096 $9.96 Million
Q3 2017 Nov 13, 2017	BUY	$23.08 - $34.92 $4.41 Million - $6.67 Million	190,956	190,956 $6.67 Million

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$223,841
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $665M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account